Tainan, Taiwan

Alan C L Tang

This inventor holds 1 USPTO granted patent. Top assignee: Industrial Technology Research Institute. Active years: 2014.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alan C L Tang: Innovator in Anticoagulant Technology

Introduction

Alan C L Tang is a prominent inventor based in Tainan, Taiwan. He has made significant contributions to the field of biomedical engineering, particularly in the development of innovative drug delivery systems. His work focuses on enhancing the efficacy and safety of therapeutic agents.

Latest Patents

One of Alan C L Tang's notable patents is titled "Anticoagulant-conjugated carbon nanocapsule, antithrombotic agent containing thereof." This invention provides a carbon nanocapsule conjugated with anticoagulants on its surface, which serves as an active ingredient in an antithrombotic drug. The anticoagulant-conjugated carbon nanocapsule is designed to exhibit less cytotoxicity and improved biocompatibility. Additionally, the patent outlines a method for preparing this innovative nanocapsule.

Career Highlights

Alan C L Tang is affiliated with the Industrial Technology Research Institute, where he continues to advance research in nanotechnology and drug delivery systems. His work has garnered attention for its potential to improve patient outcomes in the treatment of thrombotic conditions.

Collaborations

Alan has collaborated with esteemed colleagues such as Gan-Lin Hwang and Patrick C H Hsieh. Their combined expertise has contributed to the successful development of groundbreaking technologies in the biomedical field.

Conclusion

Alan C L Tang is a key figure in the innovation of anticoagulant technologies, with a focus on enhancing drug delivery systems. His contributions are paving the way for advancements in medical treatments and improving patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…